Literature DB >> 9197530

Alternative splicing of the FHIT gene in colorectal cancers.

K Hibi1, M Taguchi, H Nakamura, A Hirai, Y Fujikake, T Matsui, Y Kasai, S Akiyama, K Ito, H Takagi.   

Abstract

In the present study, we examined the status of the FHIT gene in 112 colorectal cancer and 137 colorectal adenoma specimens. In a total of 5 specimens (4 colorectal cancers and 1 colorectal adenoma), a common smaller product was detected in addition to the normal size product. This smaller product had lost exon 4, the 5' noncoding region of the FHIT gene, owing to alternative splicing. Moreover, all of the 5 tumors with alternative splicing were located lower on the rectum than the anterior peritoneal reflection.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9197530      PMCID: PMC5921425          DOI: 10.1111/j.1349-7006.1997.tb00393.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  15 in total

1.  Three distinct regions involved in 3p deletion in human lung cancer.

Authors:  K Hibi; T Takahashi; K Yamakawa; R Ueda; Y Sekido; Y Ariyoshi; M Suyama; H Takagi; Y Nakamura; T Takahashi
Journal:  Oncogene       Date:  1992-03       Impact factor: 9.867

2.  A short leader sequence impairs the fidelity of initiation by eukaryotic ribosomes.

Authors:  M Kozak
Journal:  Gene Expr       Date:  1991-05

3.  Prevalence of ras gene mutations in human colorectal cancers.

Authors:  J L Bos; E R Fearon; S R Hamilton; M Verlaan-de Vries; J H van Boom; A J van der Eb; B Vogelstein
Journal:  Nature       Date:  1987 May 28-Jun 3       Impact factor: 49.962

4.  The FHIT gene 3p14.2 is abnormal in lung cancer.

Authors:  G Sozzi; M L Veronese; M Negrini; R Baffa; M G Cotticelli; H Inoue; S Tornielli; S Pilotti; L De Gregorio; U Pastorino; M A Pierotti; M Ohta; K Huebner; C M Croce
Journal:  Cell       Date:  1996-04-05       Impact factor: 41.582

5.  The FHIT gene at 3p14.2 is abnormal in breast carcinomas.

Authors:  M Negrini; C Monaco; I Vorechovsky; M Ohta; T Druck; R Baffa; K Huebner; C M Croce
Journal:  Cancer Res       Date:  1996-07-15       Impact factor: 12.701

6.  Evaluation of the FHIT gene in colorectal cancers.

Authors:  S Thiagalingam; N A Lisitsyn; M Hamaguchi; M H Wigler; J K Willson; S D Markowitz; F S Leach; K W Kinzler; B Vogelstein
Journal:  Cancer Res       Date:  1996-07-01       Impact factor: 12.701

7.  Aberrant upregulation of a novel integrin alpha subunit gene at 3p21.3 in small cell lung cancer.

Authors:  K Hibi; K Yamakawa; R Ueda; Y Horio; Y Murata; M Tamari; K Uchida; T Takahashi; Y Nakamura; T Takahashi
Journal:  Oncogene       Date:  1994-02       Impact factor: 9.867

8.  Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients.

Authors:  I Nishisho; Y Nakamura; Y Miyoshi; Y Miki; H Ando; A Horii; K Koyama; J Utsunomiya; S Baba; P Hedge
Journal:  Science       Date:  1991-08-09       Impact factor: 47.728

9.  Loss of H19 imprinting in esophageal cancer.

Authors:  K Hibi; H Nakamura; A Hirai; Y Fujikake; Y Kasai; S Akiyama; K Ito; H Takagi
Journal:  Cancer Res       Date:  1996-02-01       Impact factor: 12.701

10.  Frequent genetic instability in small intestinal carcinomas.

Authors:  K Hibi; K Kondo; S Akiyama; K Ito; H Takagi
Journal:  Jpn J Cancer Res       Date:  1995-04
View more
  11 in total

1.  Control of 5',5'-dinucleoside triphosphate catabolism by APH1, a Saccharomyces cerevisiae analog of human FHIT.

Authors:  J Chen; A Brevet; S Blanquet; P Plateau
Journal:  J Bacteriol       Date:  1998-05       Impact factor: 3.490

2.  Decreased fragile histidine triad expression in colorectal cancer and its association with apoptosis inhibition.

Authors:  Jie Cao; Xiao-Ping Chen; Wang-Lin Li; Jie Xia; Hong Du; Wei-Biao Tang; Hui Wang; Xi-Wen Chen; Huan-Qing Xiao; Yu-Yuan Li
Journal:  World J Gastroenterol       Date:  2007-02-21       Impact factor: 5.742

3.  Absence of FHIT expression is associated with apoptosis inhibition in colorectal cancer.

Authors:  Jie Cao; Xiaoping Chen; Wanglin Li; Jie Xia; Hong Du; Weibiao Tang; Shanming Chen; Hui Wang; Xiwen Chen; Huanqing Xiao; Yuyuan Li
Journal:  Front Med China       Date:  2007-05-01

4.  FHIT protein expression and its relation to apoptosis, tumor histologic grade and prognosis in colorectal adenocarcinoma: an immunohistochemical and image analysis study.

Authors:  Hussam H Mady; Mona F Melhem
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

5.  Deletion of histidine triad nucleotide-binding protein 1/PKC-interacting protein in mice enhances cell growth and carcinogenesis.

Authors:  Tao Su; Masumi Suzui; Lei Wang; Chyuan-Sheng Lin; Wang-Qiu Xing; I Bernard Weinstein
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-16       Impact factor: 11.205

6.  Aberrant methylation of the netrin-1 receptor genes UNC5C and DCC detected in advanced colorectal cancer.

Authors:  Kenji Hibi; Hiroki Mizukami; Atsushi Shirahata; Tetsuhiro Goto; Makiko Sakata; Yutaka Sanada
Journal:  World J Surg       Date:  2009-05       Impact factor: 3.352

7.  Plasminogen activator inhibitor-1 as a potential marker for the malignancy of colorectal cancer.

Authors:  T Sakakibara; K Hibi; M Koike; M Fujiwara; Y Kodera; K Ito; A Nakao
Journal:  Br J Cancer       Date:  2005-10-03       Impact factor: 7.640

8.  Colorectal cancers with both p16 and p14 methylation show invasive characteristics.

Authors:  Kenji Hibi; Hiroshi Nakayama; Masahiko Koike; Yasushi Kasai; Katsuki Ito; Seiji Akiyama; Akimasa Nakao
Journal:  Jpn J Cancer Res       Date:  2002-08

9.  CDH13 promoter region is specifically methylated in poorly differentiated colorectal cancer.

Authors:  K Hibi; H Nakayama; Y Kodera; K Ito; S Akiyama; A Nakao
Journal:  Br J Cancer       Date:  2004-03-08       Impact factor: 7.640

10.  Reduced Fhit expression is associated with mismatch repair deficiency in human advanced colorectal carcinoma.

Authors:  H Andachi; K Yashima; M Koda; K Kawaguchi; A Kitamura; A Hosoda; Y Kishimoto; G Shiota; H Ito; M Makino; N Kaibara; H Kawasaki; Y Murawaki
Journal:  Br J Cancer       Date:  2002-08-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.